Nickel-Catalyzed Cyclization of Alkynes
FULL PAPER
(m, 9H); 13C NMR (75 MHz, CDCl3): d=13.1, 67.5, 68.6, 73.1, 125.0,
126.3 (2C), 127.1, 127.3, 127.4, 128.1, 128.6 (2C), 130.6, 132.37, 132.44,
137.7, 142.2 ppm; NMR 2D NOESY correlation between 1.66 (s, 3H)
and 4.56 (s, 2H), between 6.09 (d, J=2.1 Hz, 1H) and 7.15–7.40 ppm (m,
9H); m/z: 266 [M+], 248 [M+ꢀH2O], 233, 205, 144, 132, 105 (base), 91,
77; IR: n˜ =3417, 2914, 2852, 1449, 1105, 1021, 761, 700 cmꢀ1; HRMS (EI):
m/z calcd for C18H16O: 248.1201 [M+ꢀH2O]; found: 248.1199.
3418, 2919, 1684, 1542, 1461, 1030 cmꢀ1; HRMS (EI): m/z: calcd for
C20H28: 268.2191 [M+ꢀH2O]; found: 268.2180.
1
Compound 31: H NMR (300 MHz, CDCl3): d=0.88 (brs, 3H), 1.20–1.40
(m, 15H), 1.59 (s, 9H), 1.78 (s, 3H), 4.45 (s, 2H), 5.17 (s, 1H), 6.95 (t, J=
7.7 Hz, 1H), 7.18 (t, J=7.7 Hz, 1H), 7.47 (d, J=7.8 Hz, 1H), 7.86–
7.87 ppm (brs, 1H); 13C NMR (75 MHz, [D6]DMSO): d=14.0, 14.6, 22.1,
25.2, 28.0 (3C), 28.7, 29.0, 29.2, 31.3, 34.8, 52.6, 68.0, 74.2, 114.5, 122.2,
124.3, 125.5, 127.9, 128.3, 129.9, 134.2, 150.9 ppm, NMR 2D NOESY cor-
relation between 1.78 (s, 3H) and 4.45 (s, 2H), between 5.17 (s, 1H) and
7.47 (d, J=7.8 Hz, 1H); elemental analysis calcd (%) for C24H37NO3: C
74.38, H 9.62, N 3.61; found: C 74.50, H 9.39, N 3.50.
Compound 21: 1H NMR (300 MHz, CDCl3): d=1.72 (s, 3H), 2.35 (d, J=
3.9 Hz, 1H), 2.74–2.89 (m, 2H), 2.98–3.03 (m, 2H), 6.37 (d, J=3.9 Hz,
1H), 7.14–7.39 (m, 6H), 7.45–7.56 (m, 2H), 7.53 ppm (d, J=7.5 Hz, 1H);
13C NMR (75 MHz, CDCl3): d=15.4, 30.2, 31.8, 71.8, 124.5, 125.5, 126.1
(2C), 126.5, 127.1, 127.5, 128.4 (2C), 130.0, 140.2, 140.3, 142.1,
148.1 ppm; NMR 2D NOESY correlation between 1.72 (s, 3H) and 2.74–
2.89 (m, 2H), between 6.37 (d, J=3.9 Hz, 1H) and 7.53 ppm (d, J=
7.5 Hz, 1H); m/z: 250 [M+], 232 [M+ꢀH2O], 217 (base), 202, 115; IR:
Compound 37: 1H NMR (300 MHz, CDCl3): d Z isomer=1.90 (s, 3H),
2.63 (t, J=5.8 Hz, 2H), 3.44 (s, 2H), 3.77 (s, 3H), 4.28 (t, J=5.8 Hz, 2H),
6.83 (t, J=8 Hz, 1H), 6.86 (d, J=7.6 Hz, 1H), 7.14 (td, J=8, 1.8 Hz,
1H), 7.30 ppm (dd, J=7.6, 1.8 Hz, 1H); d E isomer=2.11 (s, 3H), 2.59
(t, J=5.8 Hz, 2H), 3.24 (s, 2H), 3.65 (s, 3H), 4.05 (t, J=5.8 Hz, 2H), 6.83
(t, J=8.0 Hz, 1H), 6.86 (d, J=7.6 Hz, 1H), 7.14 (td, J=8.0, 1.8 Hz, 1H),
7.30 ppm (dd, J=7.6, 1.8 Hz, 1H); 13C NMR (75 MHz, CDCl3): d Z
isomer=19.6, 27.9, 41.1, 52.1, 66.9, 116.7, 119.8, 122.7, 123.4, 128.5, 128.8,
129.3, 154.8, 172.9 ppm, d E isomer=21.7, 29.8, 40.4, 52.0, 67.6, 116.6,
119.2, 122.8, 123.3, 123.5, 128.6, 128.7, 154.7, 171.9 ppm, NMR 2D
NOESY Z isomer: correlation between 1.90 (s, 3H) and 2.63 (t, J=
5.8 Hz, 2H), between 3.44 (s, 2H) and 7.30 ppm (dd, J=7.6, 1.8 Hz, 1H);
E isomer correlation between 2.11 (s, 3H) and 7.28 ppm (dd, J=7.6,
1.8 Hz, 1H); m/z: 232 [M+] (base), 173, 158, 145, 131, 91, 77, 59; IR: n˜ =
n˜ =3405, 2919, 1447, 1016, 754 cmꢀ1; HRMS (EI): m/z calcd for C18H16
232.1252 [M+ꢀH2O]; found: 232.1260.
:
Compound 22: 1H NMR (300 MHz, CDCl3): d=1.60 (s, 9H), 1.68 (t, J=
1.7 Hz, 3H), 1.99 (s, 1H), 4.53 (s, 2H), 6.38 (s, 1H), 6.93 (td, J=7.8,
0.9 Hz, 1H), 7.21 (d, J=8.1 Hz, 1H), 7.30–7.35 (m, 3H), 7.43 (d, J=
7.4 Hz, 2H), 7.57 (d, J=7.8 Hz, 1H), 7.92 ppm (s, 1H); 13C NMR
(75 MHz, CDCl3): d=15.2, 28.5 (3C), 53.0, 70.6, 81.2, 115.3, 122.4, 123.9,
125.8 (2C), 127.0, 127.3, 128.4 (2C), 128.8, 129.7, 130.5, 141.5, 145.8,
151.9 ppm, NMR 2D NOESY correlation between 1.65 (s, 3H) and 4.34–
4.50 ppm (m, 2H); m/z: 350 [M+ꢀH], 349, 233 (base), 218; IR: n˜ =3412,
3052, 2980, 1703, 1472, 1383, 1163, 725 cmꢀ1; elemental analysis calcd
(%) for C22H25NO3: C 75.19, H 7.17, N 3.99; found: C 74.91, H 7.69, N
3.90.
2976, 2872, 2242, 1731, 1448, 1382, 1113, 909, 737 cmꢀ1
.
Compound 39: 1H NMR (300 MHz, CDCl3): d Z isomer=1.30 (d, J=
6.9 Hz, 3H), 1.95 (s, 3H), 2.50–2.60 (m, 1H), 2.75–2.84 (m, 1H), 3.68 (s,
3H), 3.75 (q, J=6.9 Hz, 1H), 4.18–4.26 (m, 1H), 4.28–4.37 (m, 1H),
6.79–6.88 (m, 2H), 7.12 (td, J=7.5, 1.8 Hz, 1H), 7.28 ppm (dd, J=8.4,
1.5 Hz, 1H), d E isomer=1.29 (d, J=6.9 Hz, 3H), 1.76 (s, 3H), 2.50–2.60
(m, 1H), 2.62–2.68 (m, 1H), 3.69 (q, J=6.9 Hz, 1H), 3.71 (s, 3H), 4.18–
4.26 (m, 1H), 4.28–4.37 (m, 1H), 6.79–6.88 (m, 2H), 7.19 (td, J=7.5,
1.5 Hz, 1H), 7.37 ppm (dd, J=7.5, 1.2 Hz, 1H); 13C NMR (75 MHz,
CDCl3): d Z isomer=14.9, 16.8, 27.6, 42.6, 52.0, 67.6, 116.5, 119.1, 123.6,
127.7, 128.1, 128.7, 129.5, 154.7, 174.8 ppm; dE isomer=14.8, 15.9, 27.9,
42.7, 52.1, 67.8, 116.8, 119.7, 123.5, 128.1, 128.3, 128.4, 128.8, 154.8,
175.2 ppm; NMR 2D NOESY: Z isomer correlation between 1.95 (s, 3H)
and 4.28–4.37 ppm (m, 1H); m/z: 246 [M+] (base), 215, 187, 163, 145,
120, 91; IR: n˜ =2977, 2872, 2242, 1731, 1448, 1111, 910, 741 cmꢀ1; HRMS
(EI): m/z calcd for C15H18O3: 246.1256; Z isomer found: 246.1256, E
isomer found: 246.1264.
Compound 48: 1H NMR (300 MHz, CDCl3): d=2.08 (quint, J=7.5 Hz,
2H), 2.58–2.65 (m, 2H), 2.69–2.76 (m, 2H), 6.33 (m, 1H), 7.29–7.36 (m,
2H), 7.51 (dd, J=7.8, 1.8 Hz, 1H), 7.57 (s, 1H), 7.85 ppm (dd, J=7.8,
2.4 Hz, 1H); 13C NMR (75 MHz, CDCl3): d=22.8, 33.6, 34.4, 111.7, 118.6,
121.4, 123.0, 124.5, 126.3, 126.6, 133.8, 142.2, 155.8 ppm; m/z: 184 [M+]
(base), 169, 165, 141, 127, 115, 102, 89, 77, 63, 51; HRMS (EI): m/z: calcd
for C13H12O: 184.0888; found: 184.0888.
1
Compound 23: H NMR (300 MHz, [D6]DMSO): d=1.48 (s, 3H), 4.10 (s,
2H), 5.54 (d, J=4.2 Hz, 1H), 6.01 (s, 1H), 6.13 (d, J=4.2 Hz, 1H), 6.51
(t, J=7.5 Hz, 1H), 6.58 (d, J=7.9 Hz, 1H), 6.97 (t, J=7.6 Hz, 1H), 7.21
(t, J=7H, 1H), 7.31 (t, J=7.5 Hz, 2H), 7.35–7.39 ppm (m, 3H);
13C NMR (75 MHz, [D6]DMSO): d=14.7, 51.1, 69.3, 109.4, 116.6, 123.9,
125.5, 125.6 (2C) 126.5, 128.0 (2C), 128.5, 128.6, 133.1, 143.5, 156.1 ppm;
NMR 2D NOESY correlation between 1.47 (s, 3H) and 4.09 ppm (s,
2H); m/z: 233 [M+ꢀH2O] (base), 218, 144, 116, 90, 77; elemental analysis
calcd (%) for C17H17NO: C 81.24, H 6.82, N 5.57; found: C 80.81, H 7.23,
N 5.64.
Compound 24: Isolated as a 1:1 mixture of two inseparable diastereoiso-
1
mers ratio. H NMR (300 MHz, CDCl3): d=0.83 (brs, 1H), 1.05–1.23 (m,
13H), 3.40–3.54 (m, 8H), 3.64 (s, 3H), 3.70 (s, 3H), 3.92 (s, 1H), 3.95 (s,
1H), 4.75–4.80 (m, 2H), 5.16 (s, 1H), 5.28 (s, 1H), 6.55–6.95 (m, 10H),
7.05–7.30 (m, 15H), 7.59 ppm (dd, J=7.8, 1.5 Hz, 1H); 13C NMR
(75 MHz, CDCl3): d=15.05 (2C), 15.10 (2C), 46.9, 47.8, 55.15, 55.20,
60.6, 60.79, 60.84, 60.93, 77.75, 77.82, 91.3, 91.4, 113.1, 113.3, 114.1, 114.3,
115.2, 120.9, 121.2, 122.2, 126.6, 127.1, 127.8, 127.99 (2C), 128.02 (2C),
129.3, 129.5, 130.0, 138.6, 138.7, 138.8, 140.7, 140.8, 155.2, 159.4,
159.6 ppm, m/z: 202 (base), 174, 145, 115, 103, 77; IR: n˜ =3422, 2970,
1601, 1455, 1048, 700 cmꢀ1
.
Cycloadduct endo-49: Diene 48 (0.088 g, 0.48 mmol) and N-methylmalei-
mide (0.111 g, 2 equiv, 1 mmol) were added to THF (5 mL). After 24 h
under hyperbaric conditions (16 kbar) at RT, the solvent was concentrat-
ed under reduced pressure and the crude solid was purified by column
chromatography on silica gel (pentane/AcOEt, 50:50) to provide endo-49
as a white solid (0.071 g, 50%). 1H NMR (300 MHz, CDCl3): d=1.76–
1.88 (m, 2H), 2.05–2.16 (m, 1H), 2.38–2.59 (m, 4H), 2.78 (s, 3H), 3.19 (t,
J=8.1 Hz, 1H), 3.71 (t, J=8.0 Hz, 1H), 5.11–5.16 (m, 1H), 6.91 (t, J=
7.5 Hz, 1H), 7.01 (d, J=8.1 Hz, 1H), 7.18 (t, J=7.7 Hz, 1H), 7.29 ppm
(d, J=7.5 Hz, 1H); 13C NMR (75 MHz, CDCl3): d=25.1, 27.1, 27.7, 29.9,
39.7, 41.9, 44.1, 80.9, 110.7, 121.3, 122.6, 124.1, 127.4, 129.6, 134.0, 163.4,
174.1, 177.0 ppm; NMR 2D NOESY: correlation between 2.38–2.59 (m,
4H) and 5.11–5.16 (m, 1H), between 3.19 (t, J=8.1 Hz, 1H) and 5.11–
5.16 (m, 1H), between 3.71 (t, J=8.0 Hz, 1H) and 5.11–5.16 ppm (m,
1H); m/z: 295 [M+], 210 [MꢀC2O2NMe], 197, 184 (base), 165, 152, 128,
112; HRMS (ESI+): m/z calcd for C18H18NO3: 296.1287 [M+H+]; found:
296.1297.
Compound 27: 1H NMR (300 MHz, CDCl3): d=1.62 (t, J=1.6 Hz, 3H),
2.67 (s, 1H), 3.95 (s, 3H), 5.25 (q, J=1.6 Hz, 2H), 6.34 (s, 1H), 7.27–7.38
(m, 4H), 7.43 (d, J=7.4 Hz, 2H), 7.70 (d, J=0.9 Hz, 1H), 9.73 ppm (s,
1H); 13C NMR (75 MHz, CDCl3): d=15.1, 56.2, 71.1, 76.7, 111.1, 121.1,
125.6 (2C), 126.1, 127.6, 128.6 (2C), 130.7, 130.8, 131.0, 141.2, 145.8,
158.8, 190.8 ppm; NMR 2D NOESY correlation between 1.62 (t, J=
1.6 Hz, 3H) and 5.25 (q, J=1.6 Hz, 2H), between 6.34 (s, 1H) and
7.70 ppm (d, J=0.9 Hz, 1H); m/z: 309 [M+ꢀH], 292 [M+ꢀH2O] (base),
277, 261, 249, 231, 218, 204, 189, 178, 165; elemental analysis calcd (%)
for C19H18O4: C 73.53, H 5.85; found: C 73.63, H 5.89.
1
Compound 30: H NMR (300 MHz, CDCl3): d=0.87–0.90 (m, 3H), 1.20–
1.30 (m, 14H), 1.85 (s, 3H), 2.30 (brs, 1H), 2.68–2.75 (m, 2H), 2.94 (t,
J=6.9 Hz, 2H), 5.13–5.17 (m, 1H), 7.16–7.28 (m, 3H), 7.49–7.52 ppm (m,
1H); 13C NMR (75 MHz, CDCl3): d=14.2, 14.6, 22.8, 26.1, 29.4, 29.7,
29.9, 30.2, 31.7, 32.0, 35.0, 70.7, 124.9, 125.4, 126.3, 127.1, 131.6, 138.6,
140.3, 147.9 ppm; NMR 2D NOESY correlation between 1.84 (s, 3H)
and 2.72 (m, 2H), between 5.12 (m, 1H) and 7.48 ppm (d, J=7.2 Hz,
1H); m/z: 268 [M+ꢀH2O], 183, 169 (base), 155, 141, 128, 115, 91; IR: n˜ =
Cycloadduct 50: The cycloaddition reaction was conducted under similar
conditions to those described above for endo-49 (16 kbar, RT) in pres-
Chem. Eur. J. 2011, 17, 12773 – 12783
ꢂ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
12781